RehabCo, under the direction of Pat McGlashan, has reorganized and is working to become a world class provider of state-of-the-art medical equipment and anti-cancer products. RehabCo's mandate is to be involved with "revolutionary" medical products at a cost below other similar or competing products. Our first product is the OmniBody Scan.

There will be other products.

For example, we are working on a line of anti-cancer nutrients and supplements. Our current work involves the analysis of existing products on the market and extensive research of new products. RehabCo is a division of American HealthChoice (BB: AMHI).

The data and statistics that we used came from research that is publicly available. We have not misquoted or used the data in a manner not intended. We obtained our information, statistics and data from the following sources:


he OmniBody Scan highlights areas of abnormality and is not a standalone diagnostic tool.